tiprankstipranks
Trending News
More News >
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
US Market

Monopar Therapeutics Inc (MNPR) Income Statement

Compare
523 Followers

Monopar Therapeutics Inc Income Statement

Last quarter (Q1 2025), Monopar Therapeutics Inc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Monopar Therapeutics Inc's net income was $-2.63M. See Monopar Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 16.16M$ 8.83M$ 10.54M$ 9.13M$ 6.51M
Depreciation and Amortization
$ 16.16M$ 8.83M$ 10.54M$ 9.13M$ 6.51M
EBITDA
$ -15.59M$ 429.04K$ -10.54M$ -9.13M$ -6.63M
Operating Income
$ -16.16B$ -8.83M$ -10.54M$ -9.13M$ -6.51M
Other Income/Expenses
$ 575.30M$ 429.04K$ 21.24K$ 24.02K$ 204.30K
Pretax Income
$ -15.59B$ -8.40M$ -10.52M$ -9.10M$ -6.30M
Net Income
$ -15.59B$ -8.40M$ -10.52M$ -9.10M$ -6.30M
Per Share Metrics
Basic EPS
$ -411.23$ -0.58$ -0.83$ -0.73$ -0.58
Diluted EPS
$ -411.23$ -0.58$ -0.83$ -0.73$ -0.58
Weighted Average Shares Outstanding
3.79M 14.51M 12.72M 12.47M 10.96M
Weighted Average Shares Outstanding (Diluted)
3.79M 14.51M 12.72M 12.47M 10.96M
Currency in USD

Monopar Therapeutics Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis